Morrow and Dr. Han Van Der Loo, Director, CCH Viral Vector Core
Dr. John Morrow and Dr. Kaspar Hoebe discuss research at Cincinnati Children's Hospital
Dr. Chris Mayhew and technician Amy Pitstick of Cincinnati Children's Hospital
John Morrow and Matt Gaevert discuss Kiyatec's 3D culture technology
Morrow and Mayhew consider stem cell technology at Cincinnati Children's
A visit to Biologic Covington KY
Morrow discussing Bexion technology with Dr. Neil Chaudhary
Discussing protein characterization assays at Bexion
Morrow meets with Paul Davis, CEO Quanta Biodesign
Newport Biotechnology Consultants serves the life sciences industry providing research, writing, business planning and emergency management solutions. Founder Dr. K. John Morrow Jr. (President/CEO) draws upon academic and industrial experience to cover new developments and technologies in antibody therapeutics and related areas of biotechnology. With an extensive list of publications in trade and peer-reviewed journals, we are prepared to evaluate business plans, prepare technical reports and develop advertising literature. To download some of my latest publications go to "Who We Are" page.
December 31, 2014
In my book on epigenetics I discussed how the epigenome responds to internal and external signals. Now evidence is coming together showing that exercise can activate epigenetic signals to turn on beneficial genetic signals.
December 3, 2014
A recent news article in SCIENCE (Servick, K. 2014. 346(6212):902) discusses new support for the "gay gene" hypothesis. In 1993 Dean Hamer, an investigator at NIH, carried out a study in which he identified a stretch of the X chromosome that he believed influenced an individual's predisposition t...Read More